Reaction
Blast Cells Present reporting signals
As of the last recalculation, Blast Cells Present appears in 473 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 116.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 26 | 116.0 | 116.3 |
| Imatinib | 23 | 60.3 | 60.3 |
| Ruxolitinib | 77 | 56.3 | 56.3 |
| Azacitidine For | 19 | 47.8 | 47.9 |
| Azacitidine | 29 | 45.8 | 45.8 |
| Imatinib Mesylate | 23 | 38.1 | 38.1 |
| Romiplostim | 12 | 36.0 | 36.0 |
| Venetoclax | 44 | 34.6 | 34.6 |
| Cytarabine | 43 | 34.5 | 34.6 |
| Nilotinib | 18 | 27.9 | 27.9 |
| Hydroxyurea | 13 | 27.8 | 27.8 |
| Piperacillin Sodium,Tazobactam Sodium | 16 | 27.4 | 27.5 |
| Niraparib | 9 | 18.2 | 18.2 |
| Olaparib | 7 | 14.9 | 14.9 |
| Dasatinib | 10 | 12.1 | 12.1 |